The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Open accessAbstract
Cancer is a severe health problem that continues to be a leading cause of death worldwide. Increasing knowledge of the molecular mechanisms underlying cancer progression has led to the development of a vast number of anticancer drugs. However, the use of chemically synthesized drugs has not significantly improved the overall survival rate over the past few decades. As a result, new strategies and novel chemoprevention agents are needed to complement current cancer therapies to improve efficiency. Naturally occurring compounds from plants known as phytochemicals serve as vital resources for novel drugs and are also sources for cancer therapy. Some typical examples include taxol analogs, vinca alkaloids such as vincristine, vinblastine and podophyllotoxin analogs. These phytochemicals often act via regulating molecular pathways which are implicated in growth and progression of cancer. The specific mechanisms include increasing antioxidant status, carcinogen inactivation, inhibiting proliferation, induction of cell cycle arrest and apoptosis; and regulation of the immune system. The primary objective of this review is to describe what we know to date of the active compounds in the natural products, along with their pharmacologic action and molecular or specific targets. Recent trends and gaps in phytochemical based anticancer drug discovery are also explored. The authors wish to expand the phytochemical research area not only for their scientific soundness but also for their potential druggability. Hence, the emphasis is given to information about anticancer phytochemicals which are evaluated at preclinical and clinical level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Han, M., Gao, H. Y., Xie, J., Yuan, Y., Yuan, Q., Gao, M., Liu, K.-L., Chen, X., Han, Y., & Han, Z. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0159-7 · Cited by 52
RetractedZhang, B., Fan, X., Wang, Z., Zhu, W., & Li, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.048 · Cited by 36
RetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
The influence of natural products upon drug discovery (Antiquity to late 1999)
Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293
Phase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,257
Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-12 · Cited by 1,066
Heinrich, M., & Lee Teoh, H. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.02.012 · Cited by 584
Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2404 · Cited by 573
Analysis of anticancer drugs: A review
Nussbaumer, S., Bonnabry, P., Veuthey, J.-L., & Fleury-Souverain, S. (2011) · Talanta · doi:10.1016/j.talanta.2011.08.034 · Cited by 568
Hertzberg, R. P., Caranfa, M. J., & Hecht, S. M. (1989) · Biochemistry · doi:10.1021/bi00437a018 · Cited by 551
Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
Carroll, R. E., Benya, R. V., Turgeon, D. K., Vareed, S., Neuman, M., Rodriguez, L., Kakarala, M., Carpenter, P. M., McLaren, C., Meyskens, F. L., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0098 · Cited by 503
Howells, L. M., Berry, D. P., Elliott, P. J., Jacobson, E. W., Hoffmann, E., Hegarty, B., Brown, K., Steward, W. P., & Gescher, A. J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0148 · Cited by 444
Banerjee, S., Bueso-Ramos, C., & Aggarwal, B. B. (2002) · PubMed · Cited by 423
Plant derived substances with anti-cancer activity: from folklore to practice
Fridlender, M., Kapulnik, Y., & Koltai, H. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00799 · Cited by 415
Bayet-Robert, M., Kwiatowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C., Mouret-Reynier, M.-A., Durando, X., Barthomeuf, C., & Chollet, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10392 · Cited by 399
Oudard, S., Fizazi, K., Sengeløv, L., Daugaard, G., Saad, F., Hansen, S., Hjälm-Eriksson, M., Jassem, J., Thiery-Vuillemin, A., Caffo, O., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.72.1068 · Cited by 357
Apigenin: A dietary flavonoid with diverse anticancer properties
Madunić, J., Madunić, I. V., Gajski, G., Popić, J., & Garaj-Vrhovac, V. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.10.041 · Cited by 357
Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication
van Agtmael, M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01302-4 · Cited by 346
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Martino, E., Casamassima, G., Castiglione, S., Cellupica, E., Pantalone, S., Papagni, F., Rui, M., Siciliano, A. M., & Collina, S. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.06.044 · Cited by 337
The biology of the combretastatins as tumour vascular targeting agents
TOZER, G. M., KANTHOU, C., PARKINS, C. S., & HILL, S. A. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00211.x · Cited by 335
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B. (2017) · Clinical Science · doi:10.1042/cs20160935 · Cited by 332
Kimura, Y., & Okuda, H. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.6.1844 · Cited by 313
Thangapazham, R. L., Singh, A. K., Sharma, A., Warren, J., Gaddipati, J. P., & Maheshwari, R. K. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.01.027 · Cited by 308
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Epelbaum, R., Schaffer, M., Vizel, B., Badmaev, V., & Bar-Sela, G. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.513802 · Cited by 282
Pezzani, R., Salehi, B., Vitalini, S., Iriti, M., Zuñiga, F., Sharifi-Rad, J., Martorell, M., & Martins, N. (2019) · Medicina · doi:10.3390/medicina55040110 · Cited by 264
Curcumin and Liver Cancer: A Review
S. Darvesh, A., B. Aggarwal, B., & Bishayee, A. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112798868791 · Cited by 263
de Lima, R. M. T., dos Reis, A. C., de Menezes, A. P. M., Santos, J. V. D. O., Filho, J. W. G. D. O., Ferreira, J. R. D. O., de Alencar, M. V. O. B., da Mata, A. M. O. F., Khan, I. N., Islam, A., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.6134 · Cited by 256
Zhu, W., Qin, W., Zhang, K., Rottinghaus, G. E., Chen, Y.-C., Kliethermes, B., & Sauter, E. R. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.654926 · Cited by 241
Inhibitory effects of curcumin on tumorigenesis in mice
Huang, M.-T., Newmark, H. L., & Frenkel, K. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1997)27+<26::aid-jcb7>3.0.co;2-3 · Cited by 229
A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer
Alumkal, J. J., Slottke, R., Schwartzman, J., Cherala, G., Munar, M., Graff, J. N., Beer, T. M., Ryan, C. W., Koop, D. R., Gibbs, A., et al. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0189-z · Cited by 224
Adams, L. S., Phung, S., Yee, N., Seeram, N. P., Li, L., & Chen, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3565 · Cited by 221
Yallapu, M. M., Maher, D. M., Sundram, V., Bell, M. C., Jaggi, M., & Chauhan, S. C. (2010) · Journal of Ovarian Research · doi:10.1186/1757-2215-3-11 · Cited by 221
Kanai, M., Otsuka, Y., Otsuka, K., Sato, M., Nishimura, T., Mori, Y., Kawaguchi, M., Hatano, E., Kodama, Y., Matsumoto, S., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2151-8 · Cited by 198
Mahata, S., Bharti, A. C., Shukla, S., Tyagi, A., Husain, S. A., & Das, B. C. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-39 · Cited by 187
James, M. I., Iwuji, C., Irving, G., Karmokar, A., Higgins, J. A., Griffin-Teal, N., Thomas, A., Greaves, P., Cai, H., Patel, S. R., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.005 · Cited by 185
Prasad, S., Yadav, V. R., Sung, B., Reuter, S., Kannappan, R., Deorukhkar, A., Diagaradjane, P., Wei, C., Baladandayuthapani, V., Krishnan, S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2805 · Cited by 180
Subcutaneous Apomorphine: An Evidence-Based Review of its Use in Parkinson???s Disease
Deleu, D., Hanssens, Y., & Northway, M. G. (2004) · Drugs & Aging · doi:10.2165/00002512-200421110-00001 · Cited by 177
Subramani, R., Gonzalez, E., Arumugam, A., Nandy, S., Gonzalez, V., Medel, J., Camacho, F., Ortega, A., Bonkoungou, S., Narayan, M., et al. (2016) · Scientific Reports · doi:10.1038/srep19819 · Cited by 171
Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway
Su, X., Jiang, X., Meng, L., Dong, X., Shen, Y., & Xin, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5438179 · Cited by 170
Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines
Nakamura, K., Yasunaga, Y., Segawa, T., Ko, D., Moul, J., Srivastava, S., & Rhim, J. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.4.825 · Cited by 163
ZHAO, G., HAN, X., ZHENG, S., LI, Z., SHA, Y., NI, J., SUN, Z., QIAO, S., & SONG, Z. (2016) · Oncology Reports · doi:10.3892/or.2015.4413 · Cited by 163
Pastorelli, D., Fabricio, A. S. C., Giovanis, P., D'Ippolito, S., Fiduccia, P., Soldà, C., Buda, A., Sperti, C., Bardini, R., Dalt, G. D., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.013 · Cited by 160
Saha, A., Blando, J. M., Silver, E. S., Beltrán, L., Sessler, J. L., & DiGiovanni, J. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0420 · Cited by 150
Mahammedi, H., Planchat, E., Pouget, M., Durando, X., Curé, H., Guy, L., Van-Praagh, I., Savareux, L., Atger, M., Bayet‐Robert, M., et al. (2016) · Oncology · doi:10.1159/000441148 · Cited by 144
Taverna, S., Giallombardo, M., Pucci, M., Flugy, A. M., Manno, M., Raccosta, S., Rolfo, C. D., Leo, G. D., & Alessandro, R. (2015) · Oncotarget · doi:10.18632/oncotarget.4204 · Cited by 143
Tsai, J.-P., Lee, C., Ying, T.-H., Lin, C., Lin, C., Hsueh, J.-T., & Hsieh, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4767 · Cited by 135
Paller, C. J., Rudek, M. A., Zhou, X. C., Wagner, W. D., Hudson, T., Anders, N. M., Hammers, H. J., Dowling, D., King, S., Antonarakis, E. S., et al. (2015) · The Prostate · doi:10.1002/pros.23024 · Cited by 135
Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy
Cipolla, B. G., Mandron, E., Lefort, J. M., Coadou, Y., Negra, E. D., Corbel, L., Scodan, R. L., Azzouzi, A.-R., & Mottet, N. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0459 · Cited by 135
Zhao, Y., Jing, Z., Lv, J., Zhang, Z., Lin, J., Cao, X., Zhao, Z., Liu, P., & Mao, W. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.045 · Cited by 132
Phytoagents for Cancer Management: Regulation of Nucleic Acid Oxidation, ROS, and Related Mechanisms
Lee, W.-L., Huang, J.-Y., & Shyur, L. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/925804 · Cited by 128
Tao, Y., Zhan, S., Wang, Y., Zhou, G., Liang, H., Chen, X., & Shen, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-32734-2 · Cited by 127
Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence
Dou, J., Wang, Z., Ma, L., Peng, B., Mao, K., Li, C., Su, M., Zhou, C., & Peng, G. (2018) · Oncotarget · doi:10.18632/oncotarget.24015 · Cited by 125
Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies
Mostofa, A., Hossain, M. K., Basak, D., & Sayeed, M. S. B. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00295 · Cited by 121
Chen, J., Yang, S. O. N. G., & Zhang, L. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.213 · Cited by 111
Hou, D., Xu, G., Zhang, C., Li, B., Qin, J., Hao, X., Liu, Q., Zhang, X., Liu, J., Wei, J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.471 · Cited by 108
Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats
Bhattacharya, S., Mondal, L., Mukherjee, B., Dutta, L., Ehsan, I., Debnath, M. C., Gaonkar, R. H., Pal, M. M., & Majumdar, S. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.05.011 · Cited by 105
Thymoquinone inhibits proliferation in gastric cancerviathe STAT3 pathwayin vivoandin vitro
Zhu, W., Wang, J., Guo, X., Liu, Z., & Dong, W. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i16.4149 · Cited by 104
The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Wang, Y.-C., & Bachrach, U. (2002) · Amino Acids · doi:10.1007/s007260200002 · Cited by 102
Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity
Choi, B. Y., & Kim, B.-W. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.3.185 · Cited by 102
Kim, M. O., Lee, M., Oi, N., Kim, S.-H., Bae, K. B., Huang, Z., Kim, D. J., Reddy, K., Lee, S., Park, S. J., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt365 · Cited by 100
Fujiki, H., Sueoka, E., Watanabe, T., & Suganuma, M. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.1.1 · Cited by 100
Thymol inhibits oral squamous cell carcinoma growth via mitochondria‐mediated apoptosis
Chapa, J. J. D. L., Singha, P. K., Lee, D. R., & Gonzales, C. B. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12735 · Cited by 100
Tsang, C. M., Cheung, K. C.-P., Cheung, Y. C., Man, K., Lui, V. W. Y., Tsao, S. W., & Feng, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.004 · Cited by 98
Iwanowycz, S., Wang, J., Hodge, J., Wang, Y., Yu, F., & Fan, D. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0987 · Cited by 94
Hsiao, Y., Peng, S., Lai, K., Liao, C., Huang, Y., Lin, C., Lin, M., Liu, K.-C., Tsai, C., Ma, Y., et al. (2019) · Environmental Toxicology · doi:10.1002/tox.22698 · Cited by 92
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers
Cojocneanu, R., Braicu, C., Ráduly, L., Dragoş, N., Dumitrascu, D. L., Berindan‐Neagoe, I., Zănoagă, O., & Monroig-Bosque, P. D. C. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s83597 · Cited by 90
Qazi, A. M., Pal, J., Maitah, M. Y., et al. (2010) · Translational Oncology · doi:10.1593/tlo.10235 · Cited by 88
Martin, A. C. B. M., Fuzer, A. M., Becceneri, A. B., da Silva, J. A., Tomasin, R., Denoyer, D., Kim, S.-H., McIntyre, K., Pearson, H. B., Yeo, B. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20139 · Cited by 87
Recent advances of curcumin and its analogues in breast cancer prevention and treatment
Mock, C. D., Jordan, B. C., & Selvam, C. (2015) · RSC Advances · doi:10.1039/c5ra14925h · Cited by 86
Zhang, Y., Li, Q., Zhou, D., & Chen, H. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000876 · Cited by 85
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells
Zhang, W., Su, J., Xu, H., Yu, S., Liu, Y., Zhang, Y., Sun, L., Yue, Y., & Zhou, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179672 · Cited by 84
Beynon, R. A., Richmond, R. C., Ferreira, D. L. S., Ness, A., May, M., Smith, G. D., Vincent, E. E., Adams, C. D., Ala‐Korpela, M., Würtz, P., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31929 · Cited by 84
Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway
Su, J., Yan, Y., Qu, J., Xue, X., Liu, Z., & Cai, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5428 · Cited by 81
Joo, J., Hong, S. S., Cho, Y., & Seo, D. W. (2015) · Oncology Reports · doi:10.3892/or.2015.4405 · Cited by 80
Lin, W., Zhong, M., Yin, H., Chen, Y., Cao, Q., Wang, C., & Ling, C. (2016) · Oncology Reports · doi:10.3892/or.2016.4861 · Cited by 78
Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells
Kong, Y., Chen, G., Xu, Z., Yang, G., Li, B., Wu, X., Xiao, W., Xie, B., Hu, L., Sun, X., et al. (2016) · Scientific Reports · doi:10.1038/srep37417 · Cited by 77
Li, J., Zhang, C., Jiang, H., & Cheng, J. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s76116 · Cited by 76
Irving, G. R. B., Iwuji, C., Morgan, B., Berry, D. P., Steward, W. P., Thomas, A., Brown, K., & Howells, L. M. (2015) · Trials · doi:10.1186/s13063-015-0641-1 · Cited by 75
Wu, J., Zhang, X., Wang, Y., Sun, Q., Chen, M., Liu, S., & Zou, X. (2017) · Oncology Reports · doi:10.3892/or.2017.6155 · Cited by 75
Effects of Glycyrrhizin in a Mouse Model of Lung Adenocarcinoma
Deng, Q.-P., Wang, M., Zeng, X. Z., Chen, G. G., & Huang, R.-Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000467897 · Cited by 73
Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
Das, A. M. (2017) · The Application of Clinical Genetics · doi:10.2147/tacg.s113310 · Cited by 72
Doello, K., Ortíz, R., Alvarez, P. J., Melguizo, C., Cabeza, L., & Prados, J. C. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1464347 · Cited by 72
Prasad, S., Yadav, V. R., Sung, B., Gupta, S. C., Tyagi, A. K., & Aggarwal, B. B. (2016) · Oncotarget · doi:10.18632/oncotarget.7537 · Cited by 70
Kumar, N. B., Pow‐Sang, J. M., Spiess, P. E., Park, J. Y., Salup, R. R., WILLIAMS, C. R., Parnes, H. L., & Schell, M. J. (2016) · Oncotarget · doi:10.18632/oncotarget.12222 · Cited by 69
Gee, J., Saltzstein, D. R., Kim, K., Kolesar, J., Huang, W., Havighurst, T. C., Wollmer, B. W., Stublaski, J., Downs, T. M., Mukhtar, H., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0167 · Cited by 67
Zhang, Y., Huang, L., Shi, H., Chen, H., Tao, J., Shen, R., & Wang, T. (2017) · Cancer Science · doi:10.1111/cas.13425 · Cited by 65
Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells
Suman, S., Das, T. P., Sirimulla, S., Alatassi, H., Ankem, M. K., & Damodaran, C. (2016) · Oncotarget · doi:10.18632/oncotarget.7351 · Cited by 63
Berberine: A potential adjunct for the treatment of gastrointestinal cancers?
Hesari, A., Ghasemi, F., Cicero, A. F. G., Mohajeri, M., Rezaei, O., Hayat, S. M. G., & Sahebkar, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27392 · Cited by 63
Mao, L., Chen, Q., Gong, K., Xu, X., Xie, Y., Zhang, W., Cao, H., Hu, T., Hong, X., & Zhan, Y.-Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6318 · Cited by 60
Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer
Pooladanda, V., Bandi, S., Sandhya Rani, M., Gottumukkala, K. M., & Godugu, C. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.05.010 · Cited by 55
Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level
Wu, X., Wang, W., Chen, Y., Liu, X., Wang, J., Qin, X., Yuan, D., Yu, T., Chen, G., Mi, Y.-Y., et al. (2018) · BioMed Research International · doi:10.1155/2018/6916797 · Cited by 50
Youn, D., Park, J. B., Kim, H., Jung, Y., Kang, J., Lim, S., Song, G., Kwak, H. J., & Um, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00773 · Cited by 47
A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
Kiselev, V. I., Ashrafyan, L. А., Muyzhnek, E., Викторовна, Г. Е., Antonova, I. B., Aleshikova, O. I., & Sarkar, F. H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4792-9 · Cited by 47
Abrams, S. L., Follo, M. Y., Steelman, L. S., Lertpiriyapong, K., Cocco, L., Ratti, S., Martelli, A. M., Candido, S., Libra, M., Murata, R. M., et al. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.10.003 · Cited by 45
Kim, D. H., Sung, B., Kim, J.-A., Kang, Y. J., Hwang, S. Y., Hwang, N. L., Suh, H., Choi, Y. H., Im, E., Chung, H. Y., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4058 · Cited by 43
Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells
Lin, C.-Y., Hsieh, P., Liao, Y., Peng, C., Lu, M., Yang, C.-H., Yu, C., & Liu, C. (2017) · Oncotarget · doi:10.18632/oncotarget.20723 · Cited by 42
Hu, W., Liu, J., Zhong, L., & Wang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.111 · Cited by 40
Kuppusamy, P., Nagalingam, A., Muniraj, N., Saxena, N. K., & Sharma, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-18190-4 · Cited by 34
Physapubescin B Exhibits Potent Activity against Human Prostate Cancer In Vitro and In Vivo
Ding, W., Hu, Z., Zhang, Z., Ma, Q., Tang, H., & Ma, Z. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b03045 · Cited by 32
Alpinumisoflavone suppresses tumour growth and metastasis of clear-cell renal cell carcinoma.
Wang, T., Jiang, Y., Chu, L., Wu, T., & You, J. (2017) · Europe PMC (PubMed Central) · Cited by 32
Mundy, C. A., & Kirkpatrick, P. N. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1472 · Cited by 32
Chen, L., Xia, G., Qiu, F., Wu, C., Denmon, A. P., & Zi, X. (2016) · Scientific Reports · doi:10.1038/srep32582 · Cited by 31
Lu, L., Zhao, Z., Liu, L., Gong, W., & Dong, J. (2018) · Traditional Medicine and Modern Medicine · doi:10.1142/s2575900018500131 · Cited by 30
Kotsakis, A. P., Matikas, A., Koinis, F., Kentepozidis, N. K., Varthalitis, I. I., Karavassilis, V., Samantas, E., Katsaounis, P., Dermitzaki, E. K., Hatzidaki, D., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.281 · Cited by 28
Wen, W. X., Lowe, G. N., Roberts, C. M., Finlay, J. B., Han, E. S., Glackin, C. A., & Dellinger, T. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12922-2 · Cited by 28
Choi, Y. J., Heo, K., Park, H. S., Yang, K., & Jeong, M. H. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3647 · Cited by 25
Wu, W. D., Tang, S., Zhang, Y., Puppala, M., Cooper, T. K., Xing, C., Jiang, C., & Lü, J. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500963 · Cited by 24
Can dicoumarol be used as a gonad-safe anticancer agent: anin vitroandin vivoexperimental study
TOSUN, D. A., Çınar, Ö., Cakar, Z., Özkavukçu, S., & Can, A. (2015) · Molecular Human Reproduction · doi:10.1093/molehr/gav065 · Cited by 18
Cited by
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
Ali, M. Y., Sina, A. A. I., Khandker, S. S., Neesa, L., Tanvir, E. M., Kabir, A., Khalil, M. I., & Gan, S. H. (2020) · Foods · doi:10.3390/foods10010045 · Cited by 504
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
The Role of Curcumin in Cancer Treatment
Zoi, V., Galani, V., Lianos, G. D., Voulgaris, S., Kyritsis, A. P., & Alexiou, G. A. (2021) · Biomedicines · doi:10.3390/biomedicines9091086 · Cited by 315
Metadata
- Authors
- Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P., & Prakash, O.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-01-28
- Volume
- 10
- Pages
- 1614-1614
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3003697872
- Cited by
- 1,086
- References
- 112
- FWCI
- 78.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.